Companies

Fate Therapeutics Inc

NASDAQ: FATE
$2.44
▲ $0.09 (+3.83%) today
Markets closed · 10:35pm ET

FATE Coverage

Page 2
11:50am ET
Health and Healthcare

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal master engineered induced pluripotent stem…

Chris Lange